Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentric Phase II-III Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma After a Favorable Response to Induction Chemotherapy

NCT04749108 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT04749108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04749108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentric Phase II-III Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma After a Favorable Response to Induction Chemotherapy
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Phase 2/3
Overall status
Recruiting
Start date
November 26, 2021
Completion date
September 30, 2031
Enrollment
1,075 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced malignant neoplasm, rectal carcinoma